Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder

Major Depression Disorder Clinical Trial

Status Recruiting

Clinical Trial Summary

This is a Multicenter, open lable, parallel randomized controlled clinical trial.

This study aimed to evaluate the treatment onset time, efficacy and safety in patients with major depressive disorders , accompanying anxiety receiving Buspirone and Paroxetine.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02273154
Study type	Interventional
Source	Peking University
Contact
Status	Recruiting
Phase	Phase 4
Start date	August 2014
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02773108` - Somatic Comorbidities in Psychiatric Patients
Completed	`NCT02400346` - Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment	Phase 3
Recruiting	`NCT05597566` - Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression
Recruiting	`NCT06278038` - Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder	N/A